chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: At approximately 1030 patient reports tingling and numbness in the left hand, along with soreness in the left shoulder and arm. Symptoms continued to worsen, and the patient reported this information to Dr. at 1300. Provider reviewed symptoms and referred him to FNP for further assessment. FNP evaluated the patient's injection site along with symptoms and initiate conservative care to treat symptoms.
Age: 3.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Wrong product administered
Clinical narrative: Patient received wrong vaccines.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Nausea, Pyrexia
Clinical narrative: This was Covid Shot #5 (in order of occurrence):  Extreme Exhaustion; Chills (could Not get warm); Shaking; Fever; Dizziness; Nausea; Vomiting.  After second round of vomiting, I took a Zofran Tablet (sublingually) to stop the Nausea.  When I had Shot #1 on 02/28/2021 (2-months away from my 66th birthday), my reaction was similar (but not as intense):   Extreme Exhaustion; Chills (could Not get warm); Shaking; Fever; Dizziness; Nausea.  I did NOT have any vomiting with Shot #1.  I did NOT have any reactions to Shots #2, #3, and #4.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vomiting
Clinical narrative: This was Covid Shot #5 (in order of occurrence):  Extreme Exhaustion; Chills (could Not get warm); Shaking; Fever; Dizziness; Nausea; Vomiting.  After second round of vomiting, I took a Zofran Tablet (sublingually) to stop the Nausea.  When I had Shot #1 on 02/28/2021 (2-months away from my 66th birthday), my reaction was similar (but not as intense):   Extreme Exhaustion; Chills (could Not get warm); Shaking; Fever; Dizziness; Nausea.  I did NOT have any vomiting with Shot #1.  I did NOT have any reactions to Shots #2, #3, and #4.
Age: 3.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site cellulitis, Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Vaccination was administered on 11/21/2023 as a part of his routine 3 year well visit. The following day (11/22/2023), patient's mom called complaining that vaccination site was red, warm, and firm to touch. Patient was brought into the clinic for evaluation and upon examination, a cellulitis localized to the injection site was diagnosed and the patient was started on oral antibiotics (cephalexin). On the following day (11/23/2023), the patient went to the ED for worsening and increasing area of redness. The ED switched antibiotic therapy from oral cephalexin to oral clindamycin.. Mother notes notable improvement on follow up phone call on 11/30/2023.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Patient experienced severe migraine headache a few hours after receiving her latest Covid-19 vaccine.  She felt this was very unusual as she had not had a migraine headache for 13 years.  She took Aleve and the migraine did resolve itself.  She did not need to access any medical services for this adverse event but requested that it be reported.
Age: 1.0
Sex: M
Vaccine: FLUC4
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient given booster flu shot early. Pt's family notified by Dr.
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Body temperature decreased, Fall, Headache, Loss of consciousness, Nausea
Clinical narrative: Vaccine 9:45 AM on Tuesday Dec 28th, the on Wednesday Dec 29th at 6:30 AM, brushed teeth thought I was going to vomit.  Everything got black and I knew I was going to pass out.  I grabbed door frame slid to floor and was out.  As everything turned black it was just like black with little white lines like roots in the black and then I was out.  My husband tried and woke me up.   Then I sat on toilet and vomited liquid. 7:52 AM temp 96.6    Oxy 86 7:55 AM Temp 97.8 10:00 AM Temp 98 12:27 PM Temp 95.3 1227: PM Oxy 96 12:45 PM took baby aspirin for headache 12:47 PM Temp 96.3 12:47 PM Oxy 96 12:47 PM Bpm 91
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Vomiting
Clinical narrative: Vaccine 9:45 AM on Tuesday Dec 28th, the on Wednesday Dec 29th at 6:30 AM, brushed teeth thought I was going to vomit.  Everything got black and I knew I was going to pass out.  I grabbed door frame slid to floor and was out.  As everything turned black it was just like black with little white lines like roots in the black and then I was out.  My husband tried and woke me up.   Then I sat on toilet and vomited liquid. 7:52 AM temp 96.6    Oxy 86 7:55 AM Temp 97.8 10:00 AM Temp 98 12:27 PM Temp 95.3 1227: PM Oxy 96 12:45 PM took baby aspirin for headache 12:47 PM Temp 96.3 12:47 PM Oxy 96 12:47 PM Bpm 91
Age: 77.0
Sex: M
Vaccine: COVID19, FLUX
Symptoms: Confusional state, Delirium, Pyrexia
Clinical narrative: Patient developed fever one day after receiving vaccines and then on the second day became very confused and delirious. Still with fever on day 2 and unable to say his own name.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19
Clinical narrative: hospitalized with covid
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: Glycosylated haemoglobin normal, Pruritus, Rash, Swelling face
Clinical narrative: Rash, and some swelling on the face, minimal pruritis. no shortness of breath or lightheadeness
Age: 94.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Patient was seen at Facility for vaccination clinic where their nurse completed the consent forms and brought the patient over personally due to limited knowledge of self medical history. It was not disclosed to us that the patient had been previously vaccinated. Patient was administered a flu vaccine on 11/21/23 after they had received one 2 months prior on 9/15/23. It was discovered upon data entry that the patient had been already vaccinated.
Age: 22.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Blood electrolytes, Borrelia test, Computerised tomogram head, Electromyogram
Clinical narrative: The patient first noticed that her right hand felt weaker before going into work October 16, 2023. Then the next night she started having weakness throughout the right side of her body and started limping on her right side. She was seen by her primary care doctor who referred her to the emergency room at Hospital where she was admitted for 3 days. She was treated with magnesium citrate IV, Benadryl and a series of tests were conducted. She was discharged and appointments with a neurologist, physical therapist, and her primary care doctor were made. The testing did not show any abnormal results and so she went about her life as normal. She then collapsed while at a grocery store and lost all strength in her legs and had to get a wheelchair and wheeled out of the grocery store by her husband who drove her home and helped her into bed to lie down. She has had multiple days where she has had to have her husband assist her with dressing, getting up from sitting/lying down, driving, and normal activities of daily living. She missed out on multiple days of work from this and is still not able to consistently work as she had before receiving the vaccine.
Age: 22.0
Sex: F
Vaccine: FLU4
Symptoms: Gait disturbance, Hemiparesis, Impaired driving ability, Impaired work ability, Loss of personal independence in daily activities
Clinical narrative: The patient first noticed that her right hand felt weaker before going into work October 16, 2023. Then the next night she started having weakness throughout the right side of her body and started limping on her right side. She was seen by her primary care doctor who referred her to the emergency room at Hospital where she was admitted for 3 days. She was treated with magnesium citrate IV, Benadryl and a series of tests were conducted. She was discharged and appointments with a neurologist, physical therapist, and her primary care doctor were made. The testing did not show any abnormal results and so she went about her life as normal. She then collapsed while at a grocery store and lost all strength in her legs and had to get a wheelchair and wheeled out of the grocery store by her husband who drove her home and helped her into bed to lie down. She has had multiple days where she has had to have her husband assist her with dressing, getting up from sitting/lying down, driving, and normal activities of daily living. She missed out on multiple days of work from this and is still not able to consistently work as she had before receiving the vaccine.
Age: 22.0
Sex: F
Vaccine: FLU4
Symptoms: Magnetic resonance imaging, Magnetic resonance imaging head, Magnetic resonance imaging spinal, Muscular weakness, Pregnancy test
Clinical narrative: The patient first noticed that her right hand felt weaker before going into work October 16, 2023. Then the next night she started having weakness throughout the right side of her body and started limping on her right side. She was seen by her primary care doctor who referred her to the emergency room at Hospital where she was admitted for 3 days. She was treated with magnesium citrate IV, Benadryl and a series of tests were conducted. She was discharged and appointments with a neurologist, physical therapist, and her primary care doctor were made. The testing did not show any abnormal results and so she went about her life as normal. She then collapsed while at a grocery store and lost all strength in her legs and had to get a wheelchair and wheeled out of the grocery store by her husband who drove her home and helped her into bed to lie down. She has had multiple days where she has had to have her husband assist her with dressing, getting up from sitting/lying down, driving, and normal activities of daily living. She missed out on multiple days of work from this and is still not able to consistently work as she had before receiving the vaccine.
Age: 22.0
Sex: F
Vaccine: FLU4
Symptoms: SARS-CoV-2 test, Scan with contrast, Syncope
Clinical narrative: The patient first noticed that her right hand felt weaker before going into work October 16, 2023. Then the next night she started having weakness throughout the right side of her body and started limping on her right side. She was seen by her primary care doctor who referred her to the emergency room at Hospital where she was admitted for 3 days. She was treated with magnesium citrate IV, Benadryl and a series of tests were conducted. She was discharged and appointments with a neurologist, physical therapist, and her primary care doctor were made. The testing did not show any abnormal results and so she went about her life as normal. She then collapsed while at a grocery store and lost all strength in her legs and had to get a wheelchair and wheeled out of the grocery store by her husband who drove her home and helped her into bed to lie down. She has had multiple days where she has had to have her husband assist her with dressing, getting up from sitting/lying down, driving, and normal activities of daily living. She missed out on multiple days of work from this and is still not able to consistently work as she had before receiving the vaccine.
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal discomfort, Chills, Injection site pain, Pain, Pyrexia
Clinical narrative: per patient she experienced: injection site soreness, chills, fever, bodyaches all over, GI upset for 2 days after vaccine, she is feeling better now
Sex: M
Vaccine: UNK
Symptoms: Inflammatory marker test, Laboratory test, Periorbital cellulitis, Red blood cell sedimentation rate increased, Respiratory syncytial virus infection
Clinical narrative: Patient presented to hospital at age of 33 days for periorbital cellulitis. He had a great response on IV Clindamycin. Labs were drawn in ED given age of patient. He was found to have active RSV infection but also significant elevated ESR to 89. Labs were repeated following day after significant improvement on IV Clindamycin and ESR continued to increase to 110 as other labs and inflammatory markers improved. Reporting as question of if giving RSV antibodies could cause the elevated ESR. Patient is otherwise health, in no respiratory distress, and improving on antibiotic.
Age: 32.0
Sex: M
Vaccine: HEP
Symptoms: No adverse event
Clinical narrative: Patient presented to clinic for vaccinations. Patient requested Hepatitis B Vaccine as well as COVID-19 vaccine. This RN administered the COVID-19 vaccine in the R deltoid of the patient and administered Engerix B (Hepatitis B) vaccine in the patients L deltoid. Patient monitored for 15 minutes. Patient denies any questions or concerns. Patient left building ambulatory, A&O x3.
Age: 72.0
Sex: F
Vaccine: FLU4
Symptoms: Shoulder injury related to vaccine administration
Clinical narrative: Patient reports a vaccine administration related shoulder injury.
Age: 16.0
Sex: F
Vaccine: UNK
Symptoms: Product preparation error
Clinical narrative: Patient was due for second does of Menveo. VFC menveo vaccine has to be mixed with the liquid diluent component however powder component was mixed with the Merck sterile diluent instead.
Age: 34.0
Sex: F
Vaccine: RSV
Symptoms: Exposure during pregnancy, Premature delivery, Premature labour
Clinical narrative: preterm labor that resulted in preterm delivery at 33wks 6days
Age: 1.0
Sex: F
Vaccine: FLUC4, HEPA, MMR, PNC20, VARCEL
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt received booster flu shot earlier than necessary. Dr. spoke with family to update them.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Extra dose administered, Product administration error
Clinical narrative: PATIENT DID NOT NEED A THIRD DOSE OF VACCINE TO COMPLETE SERIES
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Electroencephalogram, Headache, Impaired work ability, Magnetic resonance imaging, Seizure
Clinical narrative: 33 days after getting the first vaccine I had my first seizure. Never had on before. It?s continued f out r the past years. Also have horrible headaches to the point I miss work
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Syncope
Clinical narrative: syncopal episode
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC20, RV1
Symptoms: Abnormal behaviour, Brain injury, Cyanosis, Developmental regression, Life support
Clinical narrative: found patient unresponsive at 12:00 only hrs after receiving his vaccines cps was administered and he was blue he was put on life suport for a week and has suffered sever brain damage and is now acting the age of 2 months at 6 months old he is in physical  therapy as he is unable to move or do anything .
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC20, RV1
Symptoms: Mobility decreased, Movement disorder, Resuscitation, Unresponsive to stimuli
Clinical narrative: found patient unresponsive at 12:00 only hrs after receiving his vaccines cps was administered and he was blue he was put on life suport for a week and has suffered sever brain damage and is now acting the age of 2 months at 6 months old he is in physical  therapy as he is unable to move or do anything .
Age: 83.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Generalized body rash to arms, trunk, back and lower extremities.
Age: 18.0
Sex: F
Vaccine: HPV9, MNQ
Symptoms: Injection site erythema, Pain, Pain in extremity
Clinical narrative: Patient presented at the clinic today with erythema,  and reports of pain when using her left arm.   Patient received Gardasil 9 in the left arm, and Menquadfi in the right arm on  Wednesday, November 29th at 2:00 pm.      Patient reported that the left arm didn't hurt Thursday, but pain started early this morning, Friday, December 1,  with erythema and pain when moving her left arm.  There is a small area of erythema (1cm)  around the injection site.    There is a 2nd area of erythema approximately 9 cm below the injection site that measures 8 cm x 5 cm.   Patient reports taking Midol and Tylenol for the pain, but not getting relief.    There are no practitioners in clinic today, so patient was referred to  urgent care.
Age: 62.0
Sex: F
Vaccine: RSV
Symptoms: Rash
Clinical narrative: pt got a rash all over the body the night she received the shot.
Age: 52.0
Sex: F
Vaccine: UNK
Symptoms: Chills, Ear pain, Erythema, Nasal congestion, Nausea
Clinical narrative: Quick Left jaw neck and ear pain up from vaccination location and lasting for hours after injection. Red face, throat soreness, nasal congestion and nausea within 30 minutes. Fever and chills 2 hrs post injection, Aches and jabbing pains also beginning at this time.
Age: 52.0
Sex: F
Vaccine: UNK
Symptoms: Neck pain, Oropharyngeal pain, Pain, Pain in jaw, Pyrexia
Clinical narrative: Quick Left jaw neck and ear pain up from vaccination location and lasting for hours after injection. Red face, throat soreness, nasal congestion and nausea within 30 minutes. Fever and chills 2 hrs post injection, Aches and jabbing pains also beginning at this time.
Age: 52.0
Sex: F
Vaccine: UNK
Symptoms: Vaccination site pain
Clinical narrative: Quick Left jaw neck and ear pain up from vaccination location and lasting for hours after injection. Red face, throat soreness, nasal congestion and nausea within 30 minutes. Fever and chills 2 hrs post injection, Aches and jabbing pains also beginning at this time.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Loss of consciousness
Clinical narrative: I passed out for 5 mins after I woke up on Thursday morning. When I recovered, I was sweating profusely. My fitness tracker also recognized this anomaly (minimum heart rate 42, maximum heart rate 132). I didn't feel throbbing pain in my heart. I've had gas trouble prior to the shot so occasionally when my chest hurts, I'm not sure if it's due to the shot or moving gas. I surely passed out though (no medical history).
Age: 26.0
Sex: F
Vaccine: HPV9
Symptoms: Bursal fluid accumulation, Joint range of motion decreased, Magnetic resonance imaging abnormal, Mobility decreased, Muscle oedema
Clinical narrative: On 11/13/23 the patient reported pain and decreased ROM starting the day following HPV vaccination. She was referred for MRI which showed fluid within the subacromial/subdeltoid bursa, intramuscular edema and partial tear within the inferior infraspinatus muscle and teres minor muscle and tendon. The combination of findings was felt to represent a shoulder injury related to vaccine administration (SIRVA).
Age: 26.0
Sex: F
Vaccine: HPV9
Symptoms: Muscle strain, Pain, Shoulder injury related to vaccine administration, Tendon rupture, Ultrasound scan
Clinical narrative: On 11/13/23 the patient reported pain and decreased ROM starting the day following HPV vaccination. She was referred for MRI which showed fluid within the subacromial/subdeltoid bursa, intramuscular edema and partial tear within the inferior infraspinatus muscle and teres minor muscle and tendon. The combination of findings was felt to represent a shoulder injury related to vaccine administration (SIRVA).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: SINGLE USE VIAL MONDERNA AGE 6M -11YR 0.27 ml GIVEN TO ADULT VIAL CONTAINED 0.5ML THIS AMOUNT WAS INJECTED INTO THE LEFT DELTOID OF ADULT
Age: 51.0
Sex: M
Vaccine: FLU4
Symptoms: Injected limb mobility decreased, Joint range of motion decreased, Myalgia, Pain in extremity, Sinusitis
Clinical narrative: Muscular pain since injection and intense sinusitis within two days after the shot. Sinusitis has mostly resolved and arm pain has persisted ever since and has increased.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Anger, Blood pressure decreased
Clinical narrative: Blood pressure drop to 78/58. Have had to do electrolytes (pedilyte), Vitamin water, and supplements, Cardiotrophin PMG. Every time I try to reduce any of these, my blood pressure starts dropping. Been doing this for over two years. Normally, with this supplement you would tapper down and eventually stop taking it, but unable to do either without my blood pressure dropping down. I am able to keep it to around 100/60. If I stop any of the 3,, it drops. Stop Vitamin Water for a few weeks & it went down to 87/59.   Wished I had never taken the Covid 19 vaccine. One was almost forced into take it if you wanted to have any kind of life. With proper eating and taking immune building supplement, I never got Covid 19.  Anger that J& J vaccine was advertised as same as the childhood vaccines when it was a DNA modifier. Shame on the lies.
Sex: M
Vaccine: MMR
Symptoms: Wrong product administered
Clinical narrative: We were brining our two week old child in for a well child visit and we were recommended to get the RSV antibodies due to having an older child in daycare. Two hours later the P.A. called and stated they accidently gave him an MMR vaccine because "it was on the wrong spot in the fridge".  This was at 5pm on Friday so we were unable to get immediate feedback on the impact and chose to get additional detail outside of the healthcare system. Healthcare system has noted he did receive an MMR vaccine but has not included the detail around the brand or dosage. We were told we could no longer receive the RSV antibodies.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: MODERNA 6M -11 YR SINGLE USE VIAL  MODERNA GIVEN TO ADULT AMOUNT GIVEN .5ML
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: The patient received a 0.5ml dose of the Moderna COVID 23-24 (6M-11Y)  Pediatric formulation instead of the adult formulation. There were no reported adverse events.
Age: 60.0
Sex: M
Vaccine: RSV
Symptoms: Blood thyroid stimulating hormone normal, Computerised tomogram head normal, Contrast echocardiogram, Echocardiogram normal, Electrocardiogram normal
Clinical narrative: 60 y.o. male patient experienced numbness and weakness in the right arm, unable to squeeze his right hand.  Later experienced a low-grade headache, and then some spots in his vision.  This lasted less than 1 hour and this events were sequential. PRIMARY DIAGNOSIS: Transient Ischemic Attack (TIA) Treatment: Performed CTscan, MRI and Electrocardiogram. Including a full blood work-up. Patient was administered clopidogreL 75 mg tablet (Plavix) to reduce the future strokes. Outcome: Patient has no symptoms at time of discharge.
Age: 60.0
Sex: M
Vaccine: RSV
Symptoms: Glycosylated haemoglobin normal, Headache, Hypoaesthesia, Lipids normal, Magnetic resonance imaging head normal
Clinical narrative: 60 y.o. male patient experienced numbness and weakness in the right arm, unable to squeeze his right hand.  Later experienced a low-grade headache, and then some spots in his vision.  This lasted less than 1 hour and this events were sequential. PRIMARY DIAGNOSIS: Transient Ischemic Attack (TIA) Treatment: Performed CTscan, MRI and Electrocardiogram. Including a full blood work-up. Patient was administered clopidogreL 75 mg tablet (Plavix) to reduce the future strokes. Outcome: Patient has no symptoms at time of discharge.
Age: 60.0
Sex: M
Vaccine: RSV
Symptoms: Muscular weakness, Transient ischaemic attack, Visual impairment
Clinical narrative: 60 y.o. male patient experienced numbness and weakness in the right arm, unable to squeeze his right hand.  Later experienced a low-grade headache, and then some spots in his vision.  This lasted less than 1 hour and this events were sequential. PRIMARY DIAGNOSIS: Transient Ischemic Attack (TIA) Treatment: Performed CTscan, MRI and Electrocardiogram. Including a full blood work-up. Patient was administered clopidogreL 75 mg tablet (Plavix) to reduce the future strokes. Outcome: Patient has no symptoms at time of discharge.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Back pain, Blood urine present, Burning sensation, Cerebral disorder
Clinical narrative: 1st injection gave me UTI and severe ear ache. i was given steeds and anti botics Urgent care. heavy blood in urine. also went to urologist-GIVEN MORE ANTIBIOTICS. 2nd injection was worse, my brain and jaw went on Fire and UTI. went to ER and diagnosed with Trigaminual Nerolga. Given more Steroids and Anti bio.at  hospital.  Vision was blurry appt set up with Eye specialist still seeing her. Still sick with TN and eye pain.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deafness, Ear pain, Eye pain, Inflammation of lacrimal passage, Jaw disorder
Clinical narrative: 1st injection gave me UTI and severe ear ache. i was given steeds and anti botics Urgent care. heavy blood in urine. also went to urologist-GIVEN MORE ANTIBIOTICS. 2nd injection was worse, my brain and jaw went on Fire and UTI. went to ER and diagnosed with Trigaminual Nerolga. Given more Steroids and Anti bio.at  hospital.  Vision was blurry appt set up with Eye specialist still seeing her. Still sick with TN and eye pain.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Skin burning sensation, Therapeutic procedure, Trigeminal neuralgia, Urinary tract infection
Clinical narrative: 1st injection gave me UTI and severe ear ache. i was given steeds and anti botics Urgent care. heavy blood in urine. also went to urologist-GIVEN MORE ANTIBIOTICS. 2nd injection was worse, my brain and jaw went on Fire and UTI. went to ER and diagnosed with Trigaminual Nerolga. Given more Steroids and Anti bio.at  hospital.  Vision was blurry appt set up with Eye specialist still seeing her. Still sick with TN and eye pain.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: 1st injection gave me UTI and severe ear ache. i was given steeds and anti botics Urgent care. heavy blood in urine. also went to urologist-GIVEN MORE ANTIBIOTICS. 2nd injection was worse, my brain and jaw went on Fire and UTI. went to ER and diagnosed with Trigaminual Nerolga. Given more Steroids and Anti bio.at  hospital.  Vision was blurry appt set up with Eye specialist still seeing her. Still sick with TN and eye pain.
Age: 61.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Not on the injection site, but 2 inches away. I have a 2 1/2? x 3 1/2? red, swollen, hot and raised area.. The injection site is sore but the reaction area is on the inner side of the left arm. I have used Advil and a cool compress.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: The patient received a 0.5ml dose of the Moderna Covid 23-24 (6M-11Y) Pediatric formulation instead of the adult formulation. There were no reported side effects.
Age: 1.0
Sex: F
Vaccine: FLU4, HEPA, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Rash
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event, Product administered to patient of inappropriate age, Underdose
Clinical narrative: The patient received a 0.5ml dose of the Moderna Covid 23-24 (6M-11Y) Pediatric formulation instead of the adult formulation. There were no reported side effects.
Age: 71.0
Sex: M
Vaccine: COVID19, TD
Symptoms: Unevaluable event
Clinical narrative: Patient presented and requested the COVID 19 vaccine, Forecaster reviewed for other vaccines due, discussed with patient and patient stated they would take the tetanus vaccine also.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: PT HAD FORGOTTEN THAT THEY RECEIVED A SPIKEVAX MODERNA COVID19 VACCINATION ON 10/30/23. WAS DISCOVERED AFTER ADMINISTRATION WHEN THE PATIENT OFFERED THEIR COVID CARD FOR DOCUMENATION.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event, Product administered to patient of inappropriate age, Underdose
Clinical narrative: The patient received a 0.5ml dose of the Moderna Covid 23-24 (6M-11Y) Pediatric formulation instead of the adult formulation. There were no reported side effects.
Age: 10.0
Sex: F
Vaccine: DTAP
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: this was his first Dtap and Daptacel licensed for (6wks to 7 yrs of age) was given instead of the Tdap.  Health depart was called and we where informed that the pt does not need to repeat but will need a Tdap at the 11 yr check up
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: CALR gene mutation, Essential thrombocythaemia, Platelet count increased
Clinical narrative: Patient received her COVID vaccines on 3/16/21, 4/13/21, and 12/16/21. On 1/26/22, she saw her PCP for routine blood work, and was found to have a platelet level >900k. Subsequent testing showed plt level >1 million. She tested positive for CALR mutation on 2/9/2022 and subsequently diagnosed with essential thrombocytosis
Age: 15.0
Sex: F
Vaccine: FLUC4
Symptoms: Dizziness, Fall, Loss of consciousness, Pallor
Clinical narrative: The patient was anxious prior to vaccination and after the vaccination became dizzy and lightheaded. The patient sat in a chair, slumped over to left side of chair and according to family members lost consciousness. The patient regained consciousness in under ten seconds, remained pale and dizzy until EMS arrived. The patient was coherent and claims to not have eaten anything besides "half of a muffin" over the course of the day.  The patient left with family members walking on her own.
Age: 45.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Arthralgia, Axillary pain, Back pain, Flank pain, Injection site pain
Clinical narrative: Normal course, limited to local soreness at injection site for first 24-48 hours.   At ~50 hours since injection, noted tenderness at right sub-axillary space.  Initially thought this might be an ingrown / infected hair follicle, but did not note visible redness or inflammation in the area.  Upon palpating right armpit with left hand to assess, expressed acute pain to touch.   At rest, with arms to sides, can feel some tenderness at right axillary space; but not painful.  If I flex arms and hug arms against body as if I were cold, tenderness is more pronounced; but not painful.  Only acutely painful upon manual palpation...liken to a deep bruise or, again, how an infected hair follicle might feel.  Later in day today, I also noted some achiness in the right side, lower back.   In context, I also recalled having some joint achiness of the knees last night (prior to morning of axillary pain).  These back and knee pain may or may not be related.  Reported symptoms to clinic nurse at occupational health clinic this morning.  No additional care/interventions are pursued, beyond this report.   I have no prior history of events with vaccines, to my memory...   Contextually, this may be the first time I have had concurrent vaccine administrations , at least concurrent with COVID vaccine...
Age: 45.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Tenderness
Clinical narrative: Normal course, limited to local soreness at injection site for first 24-48 hours.   At ~50 hours since injection, noted tenderness at right sub-axillary space.  Initially thought this might be an ingrown / infected hair follicle, but did not note visible redness or inflammation in the area.  Upon palpating right armpit with left hand to assess, expressed acute pain to touch.   At rest, with arms to sides, can feel some tenderness at right axillary space; but not painful.  If I flex arms and hug arms against body as if I were cold, tenderness is more pronounced; but not painful.  Only acutely painful upon manual palpation...liken to a deep bruise or, again, how an infected hair follicle might feel.  Later in day today, I also noted some achiness in the right side, lower back.   In context, I also recalled having some joint achiness of the knees last night (prior to morning of axillary pain).  These back and knee pain may or may not be related.  Reported symptoms to clinic nurse at occupational health clinic this morning.  No additional care/interventions are pursued, beyond this report.   I have no prior history of events with vaccines, to my memory...   Contextually, this may be the first time I have had concurrent vaccine administrations , at least concurrent with COVID vaccine...
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: PT FORGOT THAT THEY HAD ALREADY GOTTEN A SPIKEVAX MODERNA VACCINE ON 10/30/23 AND REQUESTED ANOTHER ONE.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: PREP OF COVID WAS NEVER DILUTED, PATIENT RECIEVED 3 TIMES THE DOSE PRESCRIBED
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Back pain, Condition aggravated, Muscle spasms, Neuralgia
Clinical narrative: This is the second time I have received the Moderna booster and it resulted in chronic lower back pain and spasms that lasted more than one month. It also reactivated nerve pain in my hip from having the shingles virus in 2022
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain
Clinical narrative: This is the second time I have received the Moderna booster and it resulted in chronic lower back pain and spasms that lasted more than one month. It also reactivated nerve pain in my hip from having the shingles virus in 2022
Age: 8.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: was given quadracel and it is licensed for 4-6 yrs of age. the patient is 8 yrs old.  She needed to get a Tdap. we called the health department and we do not need to repeat the vaccine.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site warmth, Mobility decreased, Pain, Pain in extremity
Clinical narrative: SHOULDER PAIN, LIMITED MOBILITY IN HER ARM, THROBBING PAIN RADIATING PAIN FROM SHOULDER TO HAND, HEAT AROUND THE INJECTION SITE
Age: 10.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: PATIENTS GOT 2 FLU VACCINE BUT NO SYMPTOMS OR ANY OUTCOME
Age: 42.0
Sex: F
Vaccine: COVID19, PNC20
Symptoms: Erythema, Fatigue, Inflammation, Local reaction, Malaise
Clinical narrative: Both vaccines were administered 1 inch apart in LD, COVID was higher than the Prevnar 20 dose.   Redness and inflammation developed by ~24 th hour, increased to about 3x3 inch target areas in another 18 hrs (11/19/23 8 am) and continued to increase in redness, tenderness, and swelling over the following 24-48 hrs with the areas of inflammation merging.   Patient also experienced malaise, low grade fever, and tiredness on 11/18/23,, with resolution of systemic symptoms by the following day.    Local reaction in the left arm slowly abated over 2 weeks.
Age: 42.0
Sex: F
Vaccine: COVID19, PNC20
Symptoms: Pyrexia, Swelling, Tenderness
Clinical narrative: Both vaccines were administered 1 inch apart in LD, COVID was higher than the Prevnar 20 dose.   Redness and inflammation developed by ~24 th hour, increased to about 3x3 inch target areas in another 18 hrs (11/19/23 8 am) and continued to increase in redness, tenderness, and swelling over the following 24-48 hrs with the areas of inflammation merging.   Patient also experienced malaise, low grade fever, and tiredness on 11/18/23,, with resolution of systemic symptoms by the following day.    Local reaction in the left arm slowly abated over 2 weeks.
Age: 77.0
Sex: F
Vaccine: RSV
Symptoms: Chest pain, Injection site erythema, Injection site swelling
Clinical narrative: headache, swelling/redness around injection site; body aches and joint pain, including jaw, chest, back; extreme exhaustion .  I thought I might have been having a heart attack on Nov. 30, but the pains lessened when I changed position/laid down, etc.  I called the pharmacy the next day and found that it was the AREXVY vaccine manufactured by GSK.  I sent messages to my cardiologist at University and my primary care physician. My cardiologist advised that I report the adverse reactions to you and gave this website.  I'm back to normal with the exception of ~4" diameter swelling and redness still at the injection site.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No further AE details. No PQC.; HCP called to report a TE. TE was supported; one dose was administered on 10/11/2023. Permission to contact HCP was given. HCP was the user of the device. No further AE details. No PQC.          ?    Names of vaccines involved (including lot/exp) P; This spontaneous report was received from a nurse and refers to a 4-year-old male patient. The patient's medical history and concurrent conditions were not reported. Historical vaccines included hepatitis b vaccine, DTaP IPV HIB vaccine, pneumococcal 13 valent vaccine, hepatitis a vaccine, rotavirus vaccine, measles vaccine (+) mumps vaccine (+) rubella vaccine, influenza vaccine, varicella vaccine and covid-19 vaccine Moderna. Concomitant therapy included Diphtheria, Tetanus, acellular Pertussis and Inactivated Poliovirus Vaccine (DTaP-IPV).  On an unknown date, a temperature excursion (TE) occurred on the vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (PROQUAD) (lot #X009734, expiration date: 30-SEP-2024). It was stored at -14.3 Celsius degree (C) for 3 hours 41 mins. Previous TE was also reported: -14.9 C for 0 Hours 3 Minutes 0 Seconds; -14.6 C for 2 Hours 12 Minutes 0 Seconds; -14.6 C for 5 Hours 43 Minutes 0 Seconds; -14.6 C for 4 Hours 49 Minutes 0 Seconds; -14.3 C for 6 Hours 3 Minutes 0 Seconds; -14.2 C for 6 Hours 59 Minutes 0 Seconds; -14.3 C for 2 Hours 33 Minutes 0 Seconds; -14.6 C for 0 Hours 45 Minutes 0 Seconds; -14.6 C for 2 Hours 7 Minutes 0 Seconds; -14.8 C for 0 Hours 34 Minutes 0 Seconds; -14.5 C for 1 Hour 25 Minutes 0 Seconds; -14.8 C for 0 Hours 26 Minutes 0 Seconds; -14.8 C for 0 Hours 24 Minutes 0 Seconds; -14.8 C for 0 Hours 15 Minutes 0 Seconds; -14.5 C for 4 Hours 23 Minutes 0 Seconds; -14.1 C for 9 Hours 24 Minutes 0 Seconds; -14.2 C for 8 Hours 10 Minutes 0 Seconds; -14.2 C for 8 Hours 5 Minutes 0 Seconds; -14.2 C for 8 Hours 31 Minutes 0 Seconds; -14.2 C for 6 Hours 37 Minutes 0 Seconds.  On 11-OCT-2023, the patient received one dose of vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (PROQUAD) injection, 0.5 dosage form, subcutaneously at Left Deltoid (LD), lot #X009734, expiration date: 30-SEP-2024 (strength, and indication were not provided) (Product storage error). There was no further adverse event (AE) details and no product quality complaints (PQC).
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No further AE details. No PQC.; HCP called to report a TE. TE was supported; one dose was administered on 10/17/2023. Permission to contact HCP was given. No further AE details. No PQC.          ?    Names of vaccines involved (including lot/exp) PROQUAD Lot: X009734 EXP: 9/30/20; This spontaneous report was received from a nurse and refers to a 4-year-old female patient. The patient's medical history and concurrent conditions were not reported. Historical vaccines included hepatitis B vaccine, DTaP IPV HIB vaccine, pneumococcal 13 valent vaccine, hepatitis A vaccine, rotavirus vaccine, measles vaccine (+) mumps vaccine (+) rubella vaccine, influenza vaccine, varicella vaccine and covid-19 vaccine Moderna. Concomitant vaccine included diphtheria vaccine toxoid (+) pertussis vaccine acellular 5-component (+) polio vaccine inact 3v (mrc 5) (+) tetanus vaccine toxoid (QUADRACEL).  On an unknown date, a temperature excursion (TE) occurred on the vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (PROQUAD) (lot #X009734, expiration date: 30-SEP-2024). It was stored at -14.3 Celsius degree (C) for 3 hours 41 mins. Previous TE was also reported: -14.9 C for 0 Hours 3 Minutes 0 Seconds; -14.6 C for 2 Hours 12 Minutes 0 Seconds; -14.6 C for 5 Hours 43 Minutes 0 Seconds; -14.6 C for 4 Hours 49 Minutes 0 Seconds; -14.3 C for 6 Hours 3 Minutes 0 Seconds; -14.2 C for 6 Hours 59 Minutes 0 Seconds; -14.3 C for 2 Hours 33 Minutes 0 Seconds; -14.6 C for 0 Hours 45 Minutes 0 Seconds; -14.6 C for 2 Hours 7 Minutes 0 Seconds; -14.8 C for 0 Hours 34 Minutes 0 Seconds; -14.5 C for 1 Hour 25 Minutes 0 Seconds; -14.8 C for 0 Hours 26 Minutes 0 Seconds; -14.8 C for 0 Hours 24 Minutes 0 Seconds; -14.8 C for 0 Hours 15 Minutes 0 Seconds; -14.5 C for 4 Hours 23 Minutes 0 Seconds; -14.1 C for 9 Hours 24 Minutes 0 Seconds; -14.2 C for 8 Hours 10 Minutes 0 Seconds; -14.2 C for 8 Hours 5 Minutes 0 Seconds; -14.2 C for 8 Hours 31 Minutes 0 Seconds; -14.2 C for 6 Hours 37 Minutes 0 Seconds.  On 17-OCT-2023, the patient received one dose of vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (PROQUAD) injection, 0.5 mL, intramuscularly at Left Deltoid (LD), lot #X009734, expiration date: 30-SEP-2024 (strength, and indication were not provided) (Product storage error). There was no further adverse event (AE) details and no product quality complaints (PQC).
Sex: U
Vaccine: PNC15
Symptoms: Poor quality product administered
Clinical narrative: one syringe was given to a patient; she was not sure if the one syringe that was given to the patient also contained foreign matter or not; No AE; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, valid lot #X020316, expiration date: 18-OCT-2025, administered for prophylaxis (strength, and route of administration were not provided) (Poor quality product administered). Per reporter some syringes with the same lot number had something white floating in them (Liquid product physical issue) but was unsure if the one syringe that was given t the patient also contained foreign matter or not. No further information or adverse event was available (No adverse event).
Sex: U
Vaccine: HEP
Symptoms: Syringe issue, Underdose
Clinical narrative: Medication Leaked Out Of The Syringe During Administration And Patient May Not Have Got A Full Dose; Initial report received on 09-Nov-2023  A pharmacist in the reported that a 67-year-old male patient (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and the medication leaked out of the syringe during the administration, and patient may not have got a full dose.  Medical history, allergies, concomitant medications, and previous reactions to other vaccines at the time of vaccination were not reported.   On 06-Oct-2023, the patient received the first dose of HEPLISAV-B (Lot # 944608, expiration date 27-Jan-2026, NDC # 43528-003-05; route and site of administration not reported).   On 09-Nov-2023, 34 days after having been vaccinated with HEPLISAV-B, the patient received the second dose of HEPLISAV-B (Lot # 944608, expiration date 27- Jan-2026, NDC # 43528-003-05; route of administration not reported) in the left deltoid. It was reported that when the provider screwed the needle tip on the syringe, it wasn't straight, resulting in some of the medication to drip out of the side during administration. The provider was not sure if this was a manufacturer defect or if it was an error in placing the needle on the syringe. It was reported that the needle was secure on the syringe but not straight. The provider stated that the male patient may not have received a full dose as a result of the medication dripping out of the side. The dose that leaked was his second dose in the series.   No other information was available.  Company Comment:  The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Sex: U
Vaccine: TDAP
Symptoms: Pulmonary embolism
Clinical narrative: pulmonary embolism; This serious case was reported by a consumer and described the occurrence of pulmonary embolism in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Additional patient notes included No prior health conditions.   On an unknown date, the patient received Boostrix. On an unknown date, less than 3 months after receiving Boostrix, the patient experienced pulmonary embolism (Verbatim: pulmonary embolism) (serious criteria GSK medically significant). The outcome of the pulmonary embolism was not reported.   It was unknown if the reporter considered the pulmonary embolism to be related to Boostrix.     It was unknown if the company considered the pulmonary embolism to be related to Boostrix.   Additional Information: GSK Receipt Date: 24-NOV-2023 The patient developed pulmonary embolism for 4 times within 2.5 months of receiving the vaccine.  No prior health conditions. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pneumonia
Clinical narrative: recently hospitalized for two weeks with severe pneumonia; This serious case was reported by a consumer and described the occurrence of pneumonia in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pneumonia (Verbatim: recently hospitalized for two weeks with severe pneumonia) (serious criteria hospitalization and GSK medically significant). The outcome of the pneumonia was resolving.   It was unknown if the reporter considered the pneumonia to be related to Shingrix.     It was unknown if the company considered the pneumonia to be related to Shingrix.   Additional Information: GSK Receipt Date: 24-NOV-2023 The reporter was a patient. The patient had a question regarding the Shingrix vaccine. Patient had dose one five months and three weeks ago from reporting day. That means dose two was due within the next week from reporting day. However, the patient was recently hospitalized for two weeks with severe pneumonia. Patient was still recovering. Patient wondered if he or she could put off dose two for an additional month so patient could be fully recovered first. Patient asked a question that would he or she start the Shingrix series all over again or simply could not complete the series. Patient requested for advice. Patient wanted to be fully protected, but patient also wanted to be feeling better before he or she took dose two. The patient requested to consent to follow up.
Sex: M
Vaccine: RSV
Symptoms: Incorrect dose administered, Injection site reaction, Yellow skin
Clinical narrative: overdose; Yellow skin near injection site about 3 inches long and 1 inch wide; This non-serious case was reported by a consumer and described the occurrence of injection site discoloration in a 68-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 59K92) for prophylaxis.   Concomitant products included testosterone enanthate (Testosterone).   On 17-NOV-2023, the patient received Arexvy 1 ml. In NOV-2023, an unknown time after receiving Arexvy, the patient experienced injection site discoloration (Verbatim: Yellow skin near injection site about 3 inches long and 1 inch wide). On 17-NOV-2023, the patient experienced overdose (Verbatim: overdose). The outcome of the injection site discoloration and overdose were unknown.   It was unknown if the reporter considered the injection site discoloration to be related to Arexvy.     It was unknown if the company considered the injection site discoloration to be related to Arexvy.   Additional Information: GSK receipt date: 22-NOV-2023 The reporter reported that the he had yellow skin near injection site about 3 inches long and 1 inch wide. It was patient's concomitant medication included blood pressure medication. The patient received 1ml Arexvy which led to overdose. The reporter did not consented to follow up.